Google-founded Calico teams up with AbbVie to research treatments for age-related diseases
Calico, the Google-founded research and development company with a healthcare focus on diseases of the aging, has announced a new collaboration with AbbVie, the biopharmaceutical research offshoot of Abbott Laboratories. This R&D collaboration is designed to assist the companies with creating, developing and eventually marketing new therapies for age-related diseases, such as neurodegeneration and cancer. Calico plans to build a new R&D facility in the San Francisco Bay Area to focus specifically on aging and the diseases associated with it, and both companies say they may invest up to $1.5 billion to accelerate the development of new drugs and therapies. Calico will…
This story continues at The Next Web
The post Google-founded Calico teams up with AbbVie to research treatments for age-related diseases appeared first on The Next Web.